Tyco Spin-Off Eyes Medical Device Deals

CHICAGO (Reuters) - Covidien Ltd. (COV.N: Quote, Profile, Research), the former Tyco unit, on Monday said it expects a focus on medical technology, including small acquisitions, to help push revenue growth into the mid-single digits in the next few years. "It will continue to be the largest segment of our business and receive the majority of our investment," Richard Meelia, president and chief executive of Covidien, said in an interview.

Back to news